• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逆转肿瘤靶点:构建肿瘤陷阱

Reversing the Tumor Target: Establishment of a Tumor Trap.

作者信息

Najberg Mathie, Haji Mansor Muhammad, Boury Frank, Alvarez-Lorenzo Carmen, Garcion Emmanuel

机构信息

CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.

Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R + D Pharma Group (GI-1645), Facultad de Farmacia, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Front Pharmacol. 2019 Aug 12;10:887. doi: 10.3389/fphar.2019.00887. eCollection 2019.

DOI:10.3389/fphar.2019.00887
PMID:31456685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6699082/
Abstract

Despite the tremendous progress made in the field of cancer therapy in recent years, certain solid tumors still cannot be successfully treated. Alongside classical treatments in the form of chemotherapy and/or radiotherapy, targeted treatments such as immunotherapy that cause fewer side effects emerge as new options in the clinics. However, these alternative treatments may not be useful for treating all types of cancers, especially for killing infiltrative and circulating tumor cells (CTCs). Recent advances pursue the trapping of these cancer cells within a confined area to facilitate their removal for therapeutic and diagnostic purposes. A good understanding of the mechanisms behind tumor cell migration may drive the design of traps that mimic natural tumor niches and guide the movement of the cancer cells. To bring this trapping idea into reality, strong efforts are being made to create structured materials that imitate myelinated fibers, blood vessels, or pre-metastatic niches and incorporate chemical cues such as chemoattractants or adhesive proteins. In this review, the different strategies used (or could be used) to trap tumor cells are described, and relevant examples of their performance are analyzed.

摘要

尽管近年来癌症治疗领域取得了巨大进展,但某些实体瘤仍无法得到成功治疗。除了化疗和/或放疗等传统治疗方法外,副作用较小的靶向治疗如免疫疗法在临床上成为新的选择。然而,这些替代治疗方法可能并非对所有类型的癌症都有用,尤其是对于杀死浸润性和循环肿瘤细胞(CTC)。最近的进展致力于将这些癌细胞捕获在一个受限区域内,以便于出于治疗和诊断目的将其清除。深入了解肿瘤细胞迁移背后的机制可能会推动模仿天然肿瘤微环境并引导癌细胞移动的陷阱的设计。为了将这种捕获想法变为现实,人们正在大力努力制造模仿有髓纤维、血管或转移前微环境的结构化材料,并纳入化学信号,如化学引诱剂或粘附蛋白。在这篇综述中,描述了用于(或可用于)捕获肿瘤细胞的不同策略,并分析了它们性能的相关实例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/c078b90e04ec/fphar-10-00887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/81cd497c111f/fphar-10-00887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/74d13e3702ff/fphar-10-00887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/36d0e629c168/fphar-10-00887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/c078b90e04ec/fphar-10-00887-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/81cd497c111f/fphar-10-00887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/74d13e3702ff/fphar-10-00887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/36d0e629c168/fphar-10-00887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c78/6699082/c078b90e04ec/fphar-10-00887-g004.jpg

相似文献

1
Reversing the Tumor Target: Establishment of a Tumor Trap.逆转肿瘤靶点:构建肿瘤陷阱
Front Pharmacol. 2019 Aug 12;10:887. doi: 10.3389/fphar.2019.00887. eCollection 2019.
2
Trapping metastatic cancer cells with mechanical ratchet arrays.用机械棘轮阵列捕获转移性癌细胞。
Acta Biomater. 2023 Oct 15;170:202-214. doi: 10.1016/j.actbio.2023.08.034. Epub 2023 Aug 23.
3
Simulation and fabrication of an integrating well-aligned silicon nanowires substrate for trapping circulating tumor cells labeled with FeO nanoparticles in a microfluidic device.用于在微流控装置中捕获用FeO纳米颗粒标记的循环肿瘤细胞的集成良好排列的硅纳米线基底的模拟与制备
Bioimpacts. 2022;12(6):533-548. doi: 10.34172/bi.2022.23393. Epub 2022 Apr 12.
4
Metformin and Docosahexaenoic Acid Hybrid Micelles for Premetastatic Niche Modulation and Tumor Metastasis Suppression.二甲双胍和二十二碳六烯酸杂化胶束用于前转移龛调节和肿瘤转移抑制。
Nano Lett. 2019 Jun 12;19(6):3548-3562. doi: 10.1021/acs.nanolett.9b00495. Epub 2019 Apr 30.
5
Clinical and biological significance of circulating tumor cells in cancer.循环肿瘤细胞在癌症中的临床及生物学意义
Mol Oncol. 2016 Mar;10(3):408-17. doi: 10.1016/j.molonc.2016.01.010. Epub 2016 Feb 10.
6
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.基质的环境和细胞力学特性调节细胞迁移,并有助于癌细胞的侵袭表型。
Rep Prog Phys. 2019 Jun;82(6):064602. doi: 10.1088/1361-6633/ab1628. Epub 2019 Apr 4.
7
Adhesion receptors as therapeutic targets for circulating tumor cells.黏附受体作为循环肿瘤细胞的治疗靶点。
Front Oncol. 2012 Jul 24;2:79. doi: 10.3389/fonc.2012.00079. eCollection 2012.
8
A new glioblastoma cell trap for implantation after surgical resection.一种新的神经胶质瘤细胞陷阱,用于手术切除后的植入。
Acta Biomater. 2019 Jan 15;84:268-279. doi: 10.1016/j.actbio.2018.11.027. Epub 2018 Nov 19.
9
Understanding and overcoming resistance to immunotherapy in genitourinary cancers.了解并克服泌尿生殖系统癌症的免疫治疗抵抗。
Cancer Biol Ther. 2024 Dec 31;25(1):2342599. doi: 10.1080/15384047.2024.2342599. Epub 2024 Apr 17.
10
The Cancer Cell Dissemination Machinery as an Immunosuppressive Niche: A New Obstacle Towards the Era of Cancer Immunotherapy.癌细胞扩散机制作为免疫抑制微环境:癌症免疫治疗时代的新障碍。
Front Immunol. 2021 Apr 13;12:654877. doi: 10.3389/fimmu.2021.654877. eCollection 2021.

引用本文的文献

1
Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma.通过血脑屏障进行药物递送以治疗胶质母细胞瘤的设备辅助策略。
Commun Mater. 2025;6(1):5. doi: 10.1038/s43246-024-00721-y. Epub 2025 Jan 7.
2
Macroporous chitosan/alginate hydrogels crosslinked with genipin accumulate and retain glioblastoma cancer cells.与京尼平交联的大孔壳聚糖/海藻酸盐水凝胶会聚集并保留胶质母细胞瘤癌细胞。
RSC Adv. 2024 Nov 5;14(48):35286-35304. doi: 10.1039/d4ra06197g. eCollection 2024 Nov 4.
3
Development of a Synthetic, Injectable Hydrogel to Capture Residual Glioblastoma and Glioblastoma Stem-Like Cells with CXCL12-Mediated Chemotaxis.

本文引用的文献

1
Cancer Immunotherapy: Beyond Checkpoint Blockade.癌症免疫疗法:超越检查点阻断
Annu Rev Cancer Biol. 2019 Mar;3:55-75. doi: 10.1146/annurev-cancerbio-030518-055552. Epub 2018 Nov 7.
2
Double-layered microsphere based dual growth factor delivery system for guided bone regeneration.用于引导骨再生的基于双层微球的双生长因子递送系统。
RSC Adv. 2018 May 4;8(30):16503-16512. doi: 10.1039/c8ra02072h. eCollection 2018 May 3.
3
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates.
开发一种合成的、可注射的水凝胶,通过 CXCL12 介导的趋化作用捕获残留的胶质母细胞瘤和胶质母细胞瘤干细胞。
Adv Healthc Mater. 2023 Jun;12(14):e2300671. doi: 10.1002/adhm.202300671. Epub 2023 Apr 20.
4
Hyaluronic Acid Scaffolds for Loco-Regional Therapy in Nervous System Related Disorders.透明质酸支架在神经系统相关疾病的局部治疗中的应用。
Int J Mol Sci. 2022 Oct 12;23(20):12174. doi: 10.3390/ijms232012174.
5
Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment.胶质母细胞瘤治疗新策略开发中的药物递送系统
Pharmaceutics. 2022 Jun 1;14(6):1189. doi: 10.3390/pharmaceutics14061189.
6
The matrix-dependent 3D spheroid model of the migration of non-small cell lung cancer: a step towards a rapid automated screening.非小细胞肺癌迁移的基于基质的3D球体模型:迈向快速自动化筛查的一步。
Front Mol Biosci. 2021 Mar 25;8:610407. doi: 10.3389/fmolb.2021.610407. eCollection 2021.
7
Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells.负载雷帕霉素的脂质纳米囊泡诱导胶质母细胞瘤细胞中mTORC1信号通路的选择性抑制。
Front Bioeng Biotechnol. 2021 Feb 25;8:602998. doi: 10.3389/fbioe.2020.602998. eCollection 2020.
8
Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?胶质瘤微环境中的间充质样基质细胞:这些细胞是什么?
Cancers (Basel). 2020 Sep 15;12(9):2628. doi: 10.3390/cancers12092628.
癌症免疫疗法当前面临的挑战:提高疗效和患者反应率的多模式方法
J Oncol. 2019 Feb 28;2019:4508794. doi: 10.1155/2019/4508794. eCollection 2019.
4
Cancer survival in England: rates improve and variation falls.英格兰的癌症生存率:生存率提高,差异缩小。
BMJ. 2019 Apr 2;365:l1532. doi: 10.1136/bmj.l1532.
5
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.添加肿瘤治疗电场(TTF)治疗胶质母细胞瘤(GBM):综述
Cancers (Basel). 2019 Feb 2;11(2):174. doi: 10.3390/cancers11020174.
6
An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer.嵌合抗原受体 (CAR) T 细胞免疫疗法治疗人类癌症简介。
Am J Hematol. 2019 May;94(S1):S3-S9. doi: 10.1002/ajh.25418. Epub 2019 Feb 18.
7
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing.癌症免疫治疗的最新进展:2018 年北京癌症免疫治疗研讨会的综合回顾与展望。
J Hematol Oncol. 2018 Dec 21;11(1):142. doi: 10.1186/s13045-018-0684-3.
8
A new glioblastoma cell trap for implantation after surgical resection.一种新的神经胶质瘤细胞陷阱,用于手术切除后的植入。
Acta Biomater. 2019 Jan 15;84:268-279. doi: 10.1016/j.actbio.2018.11.027. Epub 2018 Nov 19.
9
Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children?欧美青少年和年轻成年人的癌症存活率改善是否仍落后于儿童?
Pediatr Blood Cancer. 2019 Jan;66(1):e27407. doi: 10.1002/pbc.27407. Epub 2018 Aug 19.
10
Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016.2000 年至 2016 年期间,挪威的肺癌相对存活率在全国范围内显著提高。
Lung Cancer. 2018 Aug;122:138-145. doi: 10.1016/j.lungcan.2018.06.003. Epub 2018 Jun 6.